Linda Stein‐Gold

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.

J.Q. Del Rosso, Diane Thiboutot, Richard L. Gallo et al. · PubMed · 2013 · 77 citations · Full text

Medicine, Dermatology, Pathology +15

Acne severity grading: Determining essential clinical components and features using a Delphi consensus

Jerry Tan, Barat Wolfe, Jonathan Weiss et al. · Journal of the American Academy of Dermatology · 2011 · 67 citations

Medicine, Dermatology, Pathology +13

Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.

Angela Moore, Lawrence J. Green, Suzanne Bruce et al. · PubMed · 2018 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +15

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.

J.Q. Del Rosso, Diane Thiboutot, Richard L. Gallo et al. · PubMed · 2013 · 58 citations

Medicine, Dermatology, Pharmacotherapy +8